Allertec WZF 10 mg x 10 tablets

Allertec WZF 10 mg x 10 tablets

100% secure payments
zł10.31
Tax included

Description

Allertec WZF 10 mg x 10 tablets polish

Description
Composition and form: White to cream-colored, oblong, biconvex film-coated tablets with a breakline.
The tablet can be divided into equal doses. Each film-coated tablet contains 10 mg of cetirizine dihydrochloride (Cetirizini dihydrochloridum). Excipients with known effect: lactose monohydrate and sodium. One film-coated tablet contains 31 mg of lactose monohydrate.


Indications: For adults and children aged 6 years and over. Cetirizine is indicated for the relief of nasal and ocular symptoms associated with seasonal and chronic allergic rhinitis. Cetirizine is indicated for the relief of symptoms of chronic idiopathic urticaria.
Storage and use
How to use: Use as directed by your doctor
Detailed instructions for use can be found in the leaflet included in the package.

Storage: Store at ambient temperature
Composition
Cetirizine
Manufacturer
Polfa Warszawa S.A.
Manufacturer address
Polfa Warszawa S.A.,
street Karolkowa 22/24,
01-207 Warszawa,
EN
Security Warning
There were no clinically significant interactions between alcohol (at a concentration of 0.5 g/l in blood) and cetirizine used in therapeutic doses. However, caution is advised when taking cetirizine with alcohol. Caution should be exercised in patients with risk factors for urinary retention (e.g. spinal cord injury, prostatic hyperplasia) as cetirizine may increase the risk of urinary retention.Caution is recommended when used in patients with epilepsy and in patients at risk of seizures. Antihistamines inhibit the allergic reaction in skin tests, so it is recommended to discontinue antihistamines for 3 days before testing. If you stop taking cetirizine, itching and/or hives may occur, even if these symptoms were not present before starting treatment. In some cases, these symptoms may become more severe and treatment may need to be resumed. Symptoms should disappear when treatment is resumed. Children and youth. This medicinal product is not recommended for use in children under 6 years of age as this pharmaceutical form does not allow for appropriate dose adjustments. It is recommended to use cetirizine in a pharmaceutical form intended for children. The product should not be used in patients with rare hereditary problems of galactose intolerance, the total lactase deficiency or glucose-galactose malabsorption. The product contains less than 1 mmol (23 mg) sodium per film-coated tablet, i.e. the product is essentially 'sodium-free'.

Product Details

Polpharma
7 Items

Specific References

EAN13
5909991067427

Reviews

No customer reviews for the moment.